PRESS RELEASE
News
-
-
-
-
-
-
PRESS RELEASE
Solid start to 2025 - Q1 Organic Growth tracking 3%; €321m EBITDA +5%, EBITDA margin 14.6% (+70bps); Cash generation +4%, EPS growth +22.5%
ARYZTA AG reports solid Q1 results for 2025 with 3% organic growth and €321m EBITDA, showing a 5% increase. EBITDA margin rises to 14.6% (+70bps) with cash generation up by 4% and EPS growth at 22.5% -
-
-
-
PRESS RELEASE
Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion
Onco-Innovations Limited's CEO, Thomas O'Shaughnessy, featured in an exclusive interview on Conversations That Matter discussing the Company's efforts in developing cancer treatment and strategic partnerships
